Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alice M Turner

Showing results (81-90 of 152) with videos related to

Pageof 16
Sort By:
European Respiratory Review : an Official Journal of the European Respiratory Society|June 2, 2015
Clinically relevant subgroups in COPD and asthmaAlice M Turner, Lilla Tamasi, Florence Schleich, et al.
Chest|March 13, 2025
Interventions to Improve Adherence to Clinical Guidelines for the Management and Follow-Up of Pulmonary Nodules: A Systematic ReviewJustin Aunger, Kay Por Yip, Kamen Dosanjh, et al.
International Journal of Chronic Obstructive Pulmonary Disease|June 2, 2025
The Cost-Effectiveness of a Personalised Early Warning Decision Support System (The COPDPredict™ System) to Predict and Prevent Acute Exacerbations of Chronic Obstructive Pulmonary DiseaseJames A Hall, Alice M Turner, Eleni Gkini, et al.
International Journal of Chronic Obstructive Pulmonary Disease|November 10, 2021
Alpha 1 Antitrypsin Therapy in Patients with Alpha 1 Antitrypsin Deficiency: Perspectives from a Registry Study and Practical Considerations for Self-Administration During the COVID-19 PandemicFelix J F Herth, Robert A Sandhaus, Alice M Turner, et al.
COPD|August 13, 2025
Use of a Personalised Early Warning Decision Support System for Acute Exacerbations of Chronic Obstructive Pulmonary Disease: Results of the "Predict & Prevent" Phase III TrialEleni Gkini, Rajnikant L Mehta, Sarah Tearne, et al.
Respiration; International Review of Thoracic Diseases|December 19, 2017
ICS Use May Modify FEV1 Decline in α1-Antitrypsin Deficiency Patients with Relatively High Blood EosinophilsEmma V Low, Siân M Hughes, Safia Zaffarullah, et al.
Respiratory Medicine|March 5, 2025
Bacterial colonisation doubles the risk of exacerbation in alpha-1 antitrypsin deficiencyDaniella A Spittle, Anita Pye, Jan Stanka, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|February 11, 2025
Proposal and Validation of the Minimum Clinically Important Difference in Emphysema ProgressionEmily S Y Ho, Paul R Ellis, Diana Kavanagh, et al.
ERJ Open Research|October 1, 2024
Symptoms of COPD in the absence of airflow obstruction are more indicative of pre-COPD than overdiagnosisDaniella A Spittle, Maximillian Thomas, Caitlin Stevens, et al.
Thorax|September 18, 2025
Pulmonary rehabilitation and quality of life in alpha-1 antitrypsin deficiency: findings from a retrospective cohort studyFawaz Alwadani, Paul R Ellis, Michael Newnham, et al.
Pageof 16

Showing results (81-90 of 152) with videos related to

Sort By:
Pageof 16
European Respiratory Review : an Official Journal of the European Respiratory Society|June 2, 2015
Clinically relevant subgroups in COPD and asthmaAlice M Turner, Lilla Tamasi, Florence Schleich, et al.
Chest|March 13, 2025
Interventions to Improve Adherence to Clinical Guidelines for the Management and Follow-Up of Pulmonary Nodules: A Systematic ReviewJustin Aunger, Kay Por Yip, Kamen Dosanjh, et al.
International Journal of Chronic Obstructive Pulmonary Disease|June 2, 2025
The Cost-Effectiveness of a Personalised Early Warning Decision Support System (The COPDPredict™ System) to Predict and Prevent Acute Exacerbations of Chronic Obstructive Pulmonary DiseaseJames A Hall, Alice M Turner, Eleni Gkini, et al.
International Journal of Chronic Obstructive Pulmonary Disease|November 10, 2021
Alpha 1 Antitrypsin Therapy in Patients with Alpha 1 Antitrypsin Deficiency: Perspectives from a Registry Study and Practical Considerations for Self-Administration During the COVID-19 PandemicFelix J F Herth, Robert A Sandhaus, Alice M Turner, et al.
COPD|August 13, 2025
Use of a Personalised Early Warning Decision Support System for Acute Exacerbations of Chronic Obstructive Pulmonary Disease: Results of the "Predict & Prevent" Phase III TrialEleni Gkini, Rajnikant L Mehta, Sarah Tearne, et al.
Respiration; International Review of Thoracic Diseases|December 19, 2017
ICS Use May Modify FEV1 Decline in α1-Antitrypsin Deficiency Patients with Relatively High Blood EosinophilsEmma V Low, Siân M Hughes, Safia Zaffarullah, et al.
Respiratory Medicine|March 5, 2025
Bacterial colonisation doubles the risk of exacerbation in alpha-1 antitrypsin deficiencyDaniella A Spittle, Anita Pye, Jan Stanka, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|February 11, 2025
Proposal and Validation of the Minimum Clinically Important Difference in Emphysema ProgressionEmily S Y Ho, Paul R Ellis, Diana Kavanagh, et al.
ERJ Open Research|October 1, 2024
Symptoms of COPD in the absence of airflow obstruction are more indicative of pre-COPD than overdiagnosisDaniella A Spittle, Maximillian Thomas, Caitlin Stevens, et al.
Thorax|September 18, 2025
Pulmonary rehabilitation and quality of life in alpha-1 antitrypsin deficiency: findings from a retrospective cohort studyFawaz Alwadani, Paul R Ellis, Michael Newnham, et al.
Pageof 16